Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
901 participants
INTERVENTIONAL
2020-10-30
2023-11-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All participants will be sent two devices, at no cost-an Apple Watch and a Beddit Sleep Monitor. These are publicly available, commercial devices that have not been modified for this study.
The study will be administered largely through a customized version of CareEvolution's MyDataHelps app (the "Study App"). Access to the Study App will be provided to all participants. It will be used to administer informed consent and electronic patient reported outcome (ePRO) measures, and for other study purposes. Only active arm participants will have access to Study App features designed to support asthma self-management. These features include "smart nudges" based on device data, symptom and trigger tracking, evidence-based education, summaries of health metrics gathered from the Apple Watch and Beddit Sleep Monitor, in-app medication refill resources, as well as other resources.
The study duration is 2 years. Participants can keep using the Study App and devices after Year 1, though this is not required. Primary analyses will utilize Year 1 data only. During Year 2, data collection will continue where available, though fewer data will be collected because use of digital tools is not required during Year 2, and health coverage changes may cause loss of access to claims data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Passive
Passive arm participants will be sent two devices, at no cost-an Apple Watch and a Beddit Sleep Monitor. These are commercially available and have not been modified for this study. Participants will be asked to use these devices regularly throughout study Year 1. Participants can optionally continue to use devices during Year 2, if they have met requirements during Year 1 to keep study devices. To be eligible to keep devices, participants must meet pre-specified levels of adherence to study procedures.
Access to the Study App will be provided to all participants. It will be used to administer informed consent and electronic patient reported outcome (ePRO) measures, and for other study purposes. However, passive participants will not have access to the Study App features designed to support asthma self-management.
No interventions assigned to this group
Active
Active arm participants will be sent the same devices, also at no cost, and asked to use them in the same manner.
Only the active arm will have access to Study App features for asthma self-management, including:
* "Smart nudges" that may promote proactive asthma self-management
* Asthma symptom and trigger tracking
* Evidence-based asthma education
* The ability to photograph and easily reference an asthma action plan from a healthcare provider.
* A 90-day summary of self-reported asthma symptoms/triggers and device-recorded heart rate and respiratory rate. This summary can be shared with providers.
* In-app viewing of active asthma medications, refills available, and phone numbers to call for refills (subject to prescription benefits).
Active participants can, but are not required to, use the Study App in Year 2. Those who choose to may keep using study devices in Year 2, provided they meet requirements to keep devices. These requirements are the same for both arms.
Digital Tools for Asthma Self-Management
Please see description of active study arm.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Digital Tools for Asthma Self-Management
Please see description of active study arm.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-64 years of age
* Resident of the United States for the duration of the study
* Comfortable reading and writing in English
* Owns an iPhone 6s or later
* Has been diagnosed with asthma by a provider
* 1+ emergency department visit in the preceding 24 months with an associated asthma diagnosis, or a combination of factors that might be associated with uncontrolled asthma. Factors include:
* History of asthma medication prescriptions
* History of asthma-associated primary care visits
* Diagnosis of chronic sinusitis, pharyngitis, influenza, allergic rhinitis, hypertension, diabetes, and/or obesity
* History of smoking
* Age and zip code
Exclusion Criteria
* Currently enrolled in any other asthma or pulmonary studies
* Currently on any immunologic for asthma
* Participated in a prior pilot study investigating the same digital tools
* Member of an Anthem plan with annual incentives limits of $100 or less
* Resident of Puerto Rico
* Pregnancy
* Diagnosis of any of the following:
* Chronic Obstructive Pulmonary Disease/Emphysema
* Cystic Fibrosis
* Any malignancy other than a non-melanoma skin cancer
* Any dementia diagnosis
* Neurodegenerative diseases (e.g., Parkinson's)
* Schizophrenia
* Heart failure
* On dialysis
* Women who are postpartum, with delivery in the past 8 weeks
18 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Apple Inc.
INDUSTRY
University of California, Irvine
OTHER
HealthCore, Inc.
INDUSTRY
CareEvolution, LLC
UNKNOWN
Elevance Health
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jordan Silberman
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Silberman J, Sarlati S, Harris B, Bokhari W, Boushey H, Chesnutt A, Zhu P, Sitts K, Taylor TH, Willey VJ, Fuentes E, LeKrey M, Hou E, Kaur M, Niyonkuru C, Muscioni G, Bianchi MT, Bota DA, Lee RA. A digital approach to asthma self-management in adults: Protocol for a pragmatic randomized controlled trial. Contemp Clin Trials. 2022 Nov;122:106902. doi: 10.1016/j.cct.2022.106902. Epub 2022 Aug 30.
Harris B, Silberman J, Sarlati S, et al. A digital asthma self-management tool reduced emergency visit rates in a Medicaid population. Ann Allergy Asthma Immunol. 2023;131(5):S230-S231. doi:10.1016/j.anai.2023.10.021
Silberman J, Sarlati S, Harris B, Lenyoun H, Kaur M, Wagner BG, Bokhari W, Boushey H, Chesnutt A, Sitts K, Zhu P, Willey VJ, Fuentes E, LeKrey M, Alger BL, Muscioni G, Bianchi MT, Bota DA, Taylor TH, Evans M, Amin AN, Stark D, Montanari C, Perry JS, Vian C, Patel M, Poe W, Lee RA. A Digital Asthma Self-Management Program for Adults: A Randomized Clinical Trial. JAMA Netw Open. 2025 Jul 1;8(7):e2521438. doi: 10.1001/jamanetworkopen.2025.21438.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS# 2020-5711
Identifier Type: -
Identifier Source: org_study_id